NKMAX Co. Ltd. 13D and 13G filings for NKGen Biotech, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-12-19 1:41 pm Sale |
2023-12-13 | 13D | NKGen Biotech, Inc. Common Stock NKGN |
NKMAX Co. Ltd. | 12,917,057 53.180% |
-2,453,576 (-15.96%) |
Filing |
| 2023-10-10 5:01 pm Purchase |
2023-09-29 | 13D | NKGen Biotech, Inc. Common Stock NKGN |
NKMAX Co. Ltd. | 15,370,633 63.400% |
15,370,633 (New Position) |
Filing |